Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment



Rating:

Share or cite this content

Citations should be made in the following way:
J. Chalmers (Dundee (Angus), United Kingdom). Bronchiectasis: new therapies and perspectives. International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment

Member's Comments

No comment yet.

Related content which might interest you: Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches Source: Virtual Congress 2021 – Respiratory infections Year: 2021 New molecular-directed therapies for mesothelioma: have there been any advances? Source: International Congress 2014 – Mesothelioma: a never-ending story Year: 2014 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Atypical mycobacteriosis : new drugs, new strategies Source: Annual Congress 2004 - PG11 - Multiresistant tuberculosis and atypical mycobacterial disease Year: 2004 Evidence-based medicines for children: important implications for new therapies at all ages Source: Eur Respir J 2006; 28: 1069-1072 Year: 2006 Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013 Facts and perspectives in the development of new anti-TB drugs Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008 Genomically-guided therapies: a new era for cystic fibrosis Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases Year: 2020 Facts and perspectives in the development of new diagnostics Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008 Recommendations of new therapies for severe asthma and the future Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma Year: 2013 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches Source: Eur Respir J 2006; 28: 463-465 Year: 2006 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017 Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Chronic cough: new insights and future prospects Source: Eur Respir Rev, 30 (162) 210127; 10.1183/16000617.0127-2021 Year: 2021 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008